Amesite Inc. AMST

Amesite announced a NurseMagic Enterprise win under its minimum pricing model, pricing at $1,099 per month for organizations with census up to 1,000 on a 12-month contract. Annual agreements at this level are estimated to deliver approximately 85% gross margin, supporting scalable growth across post-acute care operators. The win follows a 2.4x sequential quarterly revenue increase, 63% revenue growth from NurseMagic Enterprise, and an approximately 2,700-patient census deployment—the largest announced to date. Amesite says the pricing structure creates repeatable sales for smaller operators while preserving larger opportunities for multi-location enterprises, and that deployments do not require replacing existing EMRs, aided by increased interoperability. CEO Dr. Ann Marie Sastry and AI head Sai Nittala emphasize margins and repeatable sales, with engineering noting broader EMR support to enable scaling. High-margin, scalable pricing validation could accelerate larger multi-location deals and long-term growth.

Amesite Inc. (AMST) stock surged 150% after the company announced a new enterprise deal. New enterprise deal triggers major stock surge and signals potential shift in company trajectory.

Amesite Inc. (AMST) announces its largest AI healthcare deployment, triggering a 250% stock surge. Largest AI healthcare deployment drives 250% stock surge and signals major growth for Amesite.

Amesite Inc. (AMST) shares skyrocketed after securing its largest enterprise client to date. Securing the largest enterprise client drives major revenue growth and lifts Amesite's market trajectory.

Amesite Inc. secured a contract for its NurseMagic platform with a home care enterprise serving a 2,700-patient census. Enterprise customer win adds revenue visibility and market validation but remains one contract amid broader execution risks.

Amesite Inc. (AMST) closed a concurrent registered direct offering and private placements raising up to $7.8 million, priced at-the-market under Nasdaq rules. Securing up to $7.8 million in funding via offerings provides substantial capital to support operations and growth, significantly impacting financial position and market performance.

Amesite Inc. (AMST) announces insider-led private placement priced at a premium to market. Insider-led funding at a premium signals strong confidence and provides immediate capital for operations.

Amesite Inc. (AMST) announced a $6 million concurrent registered direct offering and private placement. $6M capital raise via direct offering and private placement provides significant funding to support operations and growth for the small-cap company.

Amesite Inc. (AMST) announced a concurrent registered direct offering and private placement to raise up to $6 million, priced at-the-market under Nasdaq rules. Up to $6 million capital raise via direct offering and private placement constitutes a significant financing event that could support growth but risks dilution.

Amesite Inc. (AMST) announces withdrawal of its Registration Statement on Form S-1. Withdrawal of S-1 registration halts planned securities offering, significantly impairing capital access and investor confidence.

Amesite Inc. (AMST) executed a Trading Partner Agreement enabling secure connectivity with a leading homecare technology platform. The trading partner agreement enables secure connectivity to a leading homecare platform, moderately boosting Amesite's market access and competitive positioning in homecare tech.

Amesite Inc. has launched NurseMagic EMR, an AI-native electronic medical record system designed to enhance healthcare efficiency and patient care. The platform integrates advanced AI capabilities to streamline workflows and improve data management for healthcare providers. This innovative solution aims to address the growing demand for effective digital tools in the medical field, positioning Amesite as a key player in the healthcare technology sector. The introduction of an AI-native EMR system represents a significant strategic move that could enhance Amesite's competitive positioning in the healthcare technology market.

Amesite Inc. has launched NurseMagic™, an AI-native electronic medical record (EMR) system designed to enhance healthcare efficiency and improve patient outcomes. This innovative platform aims to streamline workflows for healthcare professionals, leveraging artificial intelligence to optimize data management and patient care processes. The introduction of NurseMagic™ is part of Amesite's strategy to expand its offerings in the healthcare sector, positioning the company for accelerated growth in a rapidly evolving market. The launch of NurseMagic™ represents a significant strategic move that could enhance Amesite's competitive position in the healthcare technology market.

Amesite Inc. reported a 69% quarter-over-quarter revenue increase for Q2 2026, highlighting strong financial performance. The company also outlined its product plans for the upcoming months, indicating a focus on innovation and growth in its offerings. The significant revenue increase and product plans suggest a major strategic move that could enhance Amesite's market position.

Amesite Inc. reported a 63% revenue growth from its NurseMagic™ Enterprise platform and announced the launch of an AI-powered government form-fill automation tool aimed at reducing reporting burdens for clients. This new initiative is expected to enhance operational efficiency and support the company's growth strategy. The launch of AI-powered automation tools represents a significant strategic move that could enhance operational efficiency and market positioning.

Amesite Inc. (AMST) has been highlighted as one of the most active stocks in the market, indicating increased trading volume and investor interest. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.

Amesite Inc. insiders have purchased approximately US$1.26 million worth of stock, indicating their confidence in the company's future. This significant investment by insiders may reflect positive expectations regarding Amesite's performance and growth potential. Insider buying can signal confidence in the company's future, potentially influencing market sentiment and stock performance.

Amesite Inc. has launched the NurseMagic™ Enterprise Tier, designed for mid- and large-scale post-acute healthcare providers. This new offering features seamless EMR integration, automated interdisciplinary team reporting, and custom documentation support, all tied to patient census for scalable pricing. The launch aims to meet enterprise demand and significantly expand Amesite's total addressable market, enhancing revenue growth potential. Existing entry-level B2B Teams plan sales will be discontinued, focusing on the new NurseMagic™ Enterprise and Teams Plus+ tiers. The company believes this strategic shift will drive stronger recurring revenue growth. The launch of the NurseMagic™ Enterprise Tier represents a significant strategic move that could enhance revenue and market positioning.

Amesite Inc.'s NurseMagic™ app, which is compliant with HIPAA regulations, has expanded its language capabilities to 16 languages, enhancing access to AI-powered charting for nearly 1 million nurses in the U.S. This development aims to improve communication and efficiency in healthcare settings, making the app more accessible to a diverse workforce. The expansion of the NurseMagic™ app to 16 languages significantly enhances its market reach and potential user base, likely impacting future performance positively.

Amesite Inc. (NASDAQ:AMST) reported a net loss of US$663.4k for the third quarter of 2025, improving from a US$1.45 million loss in the same period last year, resulting in a loss per share of US$0.16 compared to US$0.56 in 3Q 2024. The company's shares have increased by 37% over the past week. However, there are five warning signs regarding Amesite's performance that investors should consider. The narrowing of losses indicates potential improvement in financial performance, but the presence of warning signs suggests that challenges remain.

Amesite Inc. reported a quarterly revenue increase of 2.4 times in its 10-Q filing, highlighting significant growth in its financial performance. The company continues to expand its offerings and market presence, indicating a positive trajectory for future operations. The substantial revenue growth suggests a significant impact on future performance and investor sentiment.

Amesite Inc. has launched a higher-priced enterprise tier of its NurseMagicTM app, responding to increased demand from businesses for more capacity and advanced analytics. The new Teams Plus+ tier offers 24/7 access to analytics, aiming to improve efficiency and drive growth. The company reports strong customer willingness-to-pay for enhanced services, with a notable increase in enterprise clients utilizing the app across various roles. CEO Dr. Ann Marie Sastry highlighted the demand for services that alleviate documentation stress, showcasing the product's success since its B2B launch. Amesite continues to meet HIPAA regulations and expand its offerings in the healthcare sector. The launch of a new service tier in response to strong B2B demand is likely to significantly impact future performance and market positioning.

Amesite Inc. announced that its NurseMagic™ platform now meets HIPAA requirements for individual users, in addition to its existing compliance for enterprise users. This development enhances the platform's accessibility and security for personal use, potentially expanding its market reach and user base. Meeting HIPAA requirements for individual users significantly enhances the platform's credibility and market potential.

Amesite Inc. (NASDAQ: AMST) reports that its operations remain unaffected by recent U.S. tariffs due to its U.S.-based workforce and cloud-native infrastructure. CEO Dr. Ann Marie Sastry highlights that rising costs and demand for efficient solutions like NurseMagic™ are driving sales growth. The platform significantly reduces documentation time for healthcare professionals, positioning Amesite strongly in the home health industry. The company aims to transform the $330 billion healthcare market with its AI-driven solutions, which comply with HIPAA regulations and support users across 50 states and 21 countries. Amesite's strong positioning in the home health industry and the increasing demand for its AI-powered solutions indicate a significant impact on future performance.

Amesite Inc. announced the successful soft rollout of its NurseMagic™ caregiver solution, targeting non-clinical healthcare workers and expanding its addressable market by 50%. The company reported a significant increase in contracts with hospice providers, growing by over 3,000%, and contract sizes increasing by nearly 1,000%. The automated purchase process has streamlined contract expansion, allowing for quicker sales cycles. Amesite aims to transform the $330 billion healthcare market with its AI-driven solutions, which improve operational efficiency and patient care while meeting HIPAA regulations. The expansion of the NurseMagic™ solution and significant contract growth indicate a major strategic move that could significantly alter the company's trajectory and investor sentiment.

Amesite Inc. (NASDAQ:AMST) is utilizing its AI-driven NurseMagic solution to enhance hospice care by optimizing documentation workflows and improving patient communication. The company recently announced the integration of its Hospice Notes tool, which has led to a 3,000% increase in NurseMagic sales over three months. This HIPAA-compliant solution aims to streamline documentation for faster reimbursement, ultimately improving operational efficiency and care quality in the healthcare sector. Amesite ranks 10th among AI stocks to watch, with a focus on delivering higher returns compared to other AI investments. The significant sales growth and strategic adoption of AI tools in hospice care are likely to impact Amesite's market performance and investor sentiment positively.

Amesite Inc. reported sales growth for its NurseMagic™ documentation solution, specifically designed for hospice care teams. This solution aims to ensure reimbursements and reduce audit risks for owners, highlighting its importance in the healthcare sector. The growth reflects the increasing demand for efficient documentation tools in hospice care, positioning Amesite favorably in the market. The sales growth of NurseMagic™ indicates a significant strategic move that could enhance Amesite's market position and financial performance.

Amesite Inc. (NASDAQ:AMST) has enhanced its NurseMagic tool, achieving a 95% reduction in enterprise onboarding time, allowing clients to complete subscriptions in minutes. This improvement is expected to boost sales conversion and technology adoption while minimizing audit risks. The company emphasizes the importance of speed in healthcare sales, linking it to better patient care. AMST ranks 8th among AI stocks that investors may have overlooked, with a focus on the potential for higher returns in AI investments. The significant reduction in onboarding time for NurseMagic could greatly enhance sales and operational efficiency, impacting future performance positively.

Amesite Inc. announced the success of its automated sales flow for NurseMagic™, significantly reducing the time to close enterprise sales by over 95%. Targeting home care, home health care, and hospice sectors, the solution allows customers to complete subscriptions within minutes, enhancing operational efficiency and patient care. The addressable market exceeds $360 billion annually, with over 50,000 U.S. businesses. The platform meets HIPAA regulations and facilitates seamless onboarding and license management. Amesite aims to transform the healthcare industry, which presents a $600 billion opportunity for AI-driven solutions by 2034. The automated sales flow and rapid onboarding capabilities are likely to significantly enhance Amesite's market position and operational efficiency in a large addressable market.

Amesite Inc. (Nasdaq: AMST) is being recognized by Nasdaq for its progress in launching the AI app NurseMagic™, aimed at nursing professionals and home health care workers. CEO Dr. Ann Marie Sastry highlighted the app's rapid adoption across all 50 U.S. states and 21 countries, emphasizing its value in the $130 billion healthcare sector. NurseMagic™ enhances efficiency in patient care tasks and documentation, offering tools for creating nursing notes in various formats. The company has received positive testimonials from customers, validating its market fit. The launch of NurseMagic™ and its rapid adoption in a significant market indicates a major strategic move that could significantly alter the company's trajectory.